Risperdal Breast Growth Lawsuits

Sponsored by Hissey-Kientz - Committed to protecting your legal rights.
Call us Toll Free at 866-275-4454 for a FREE Consultation
Help and information about Testosterone lawsuit issues.

J&J pays small fraction of original Risperdal settlement

May 29th, 2015

After an appeal, drug giant Johnson & Johnson  is only paying $7.8 million in a Risperdal settlement, a fraction of the $1.2 billion fine imposed by an Arkansas judge. The state of Arkansas alleged that J&J and its subsidiary Janssen Pharmaceuticals violated consumer protection laws by illegally marketing antipsychotic Risperdal for unapproved uses.

The state charged Janssen with downplaying the risks associated with Risperdal, including the risk of gynecomastia, or breast tissue development in boys and male adolescents who use the drug. The Risperdal lawsuit against the drug’s manufacturers began nearly eight years ago.

Risperdal has been found to potentially increase levels of prolactin, a hormone responsible for breast tissue growth, for an indefinite period of time. Many male patients who have been giving the drug to treat schizophrenia, bipolar disorder and symptoms of ADHD claim that their breast growth was due to the drug.


Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields